SU 5416
Tocris Bioscience | Catalog # 3037
Key Product Details
Description
Alternative Names
Product Description
SU 5416, an angiogenesis inhibitor, is a potent vascular endothelial growth factor receptor tyrosine kinase 1/2 inhibitor (IC50 = 40 nM). SU 5416 also potently inhibits c-Kit, FLT3 and RET tyrosine kinases (IC50 values are 30 nM, 160 nM and 170 nM, respectively). SU 5416 shows inhibition of tumour growth and vascularization and can be used to generate an animal model of pulmonary arterial hypertension.
Product Specifications for SU 5416
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 23.83 | 100 |
Preparing Stock Solutions for SU 5416
The following data is based on the product molecular weight 238.28.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 4.20 mL | 20.98 mL | 41.97 mL |
| 5 mM | 0.84 mL | 4.20 mL | 8.39 mL |
| 10 mM | 0.42 mL | 2.10 mL | 4.20 mL |
| 50 mM | 0.08 mL | 0.42 mL | 0.84 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 109 publications citing the usage of this product.
- Ciuclan A novel murine model of severe pulmonary arterial hypertension. Am.J.Respir.Crit. Care Med. 2011 PMID: 21868504
- Smolich The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-Kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts. Blood 2001 PMID: 11222388
- Mologni Inhibition of RET tyrosine kinase by SU5416. J.Mol.Endocrinol. 2006 PMID: 17032739
- Fong SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularisation, and growth of multiple tumor types. Cancer Res. 1999 PMID: 9892193
Product Documents for SU 5416
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for SU 5416
For research use only
Related Research Areas
Citations for SU 5416
Customer Reviews for SU 5416 (1)
Have you used SU 5416?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
-
Assay Type: In VivoCell Line/Tissue: Also used in ratVerified Customer | Posted 12/01/2017We study rodent models of pulmonary hypertension where we inject SU5416 in addition to placing the animals in hypoxia to exacerbate the PH phenotype
There are no reviews that match your criteria.